RECARBRIO FDA approval date

The FDA approved RECARBRIO on 16 Jul 2019.

FDA approval date
16 Jul 2019

Drug identity has not yet been verified against registry records

Also recorded as CILASTATIN SODIUM; IMIPENEM; RELEBACTAM

Included trials

No linked trials for this drug yet. Browse all trials

PDUFA dates and FDA decisions

Date as reportedDrug / companyEventConditionEvidence
2019-07-16DayRECARBRIOFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA212819", "applicant_as_listed_by_fda": "MSD MERCK CO", "brand_names": ["RECARBRIO"], "active_ingredients": ["CILASTATIN SODIUM", "IMIPENEM", "RELEBACTAM"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20190716", "matched_on": "drug record created from this FDA brand name"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026